Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists, have an increased risk of diabetes and cardiovascular disease, according to a new study.
Higher risk for heart disease and diabetes associated with androgen deprivation therapy
December 10th, 2009 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.